Literature DB >> 35699810

Treatment of Oligometastatic Esophagogastric Cancer: A Spark of Light at the End of the Tunnel.

Lucas Goense1.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35699810     DOI: 10.1245/s10434-022-11809-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  7 in total

1.  Oligometastases.

Authors:  S Hellman; R R Weichselbaum
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

2.  Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.

Authors:  Salah-Eddin Al-Batran; Nils Homann; Claudia Pauligk; Thorsten O Goetze; Johannes Meiler; Stefan Kasper; Hans-Georg Kopp; Frank Mayer; Georg Martin Haag; Kim Luley; Udo Lindig; Wolff Schmiegel; Michael Pohl; Jan Stoehlmacher; Gunnar Folprecht; Stephan Probst; Nicole Prasnikar; Wolfgang Fischbach; Rolf Mahlberg; Jörg Trojan; Michael Koenigsmann; Uwe M Martens; Peter Thuss-Patience; Matthias Egger; Andreas Block; Volker Heinemann; Gerald Illerhaus; Markus Moehler; Michael Schenk; Frank Kullmann; Dirk M Behringer; Michael Heike; Daniel Pink; Christian Teschendorf; Carmen Löhr; Helga Bernhard; Gunter Schuch; Volker Rethwisch; Ludwig Fischer von Weikersthal; Jörg T Hartmann; Michael Kneba; Severin Daum; Karsten Schulmann; Jörg Weniger; Sebastian Belle; Timo Gaiser; Fuat S Oduncu; Martina Güntner; Wael Hozaeel; Alexander Reichart; Elke Jäger; Thomas Kraus; Stefan Mönig; Wolf O Bechstein; Martin Schuler; Harald Schmalenberg; Ralf D Hofheinz
Journal:  Lancet       Date:  2019-04-11       Impact factor: 79.321

3.  Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe.

Authors:  Tiuri E Kroese; Richard van Hillegersberg; Sebastian Schoppmann; Pieter R A J Deseyne; Philippe Nafteux; Radka Obermannova; Marianne Nordsmark; Per Pfeiffer; Maria A Hawkins; Elizabeth Smyth; Sheraz Markar; George B Hanna; Edward Cheong; Asif Chaudry; Anneli Elme; Antoine Adenis; Guillaume Piessen; Cihan Gani; Christiane J Bruns; Markus Moehler; Theodore Liakakos; John Reynolds; Alessio Morganti; Riccardo Rosati; Carlo Castoro; Domenico D'Ugo; Franco Roviello; Maria Bencivenga; Giovanni de Manzoni; Paul Jeene; Johanna W van Sandick; Christel Muijs; Marije Slingerland; Grard Nieuwenhuijzen; Bas Wijnhoven; Laurens V Beerepoot; Piotr Kolodziejczyk; Wojciech P Polkowski; Maria Alsina; Manuel Pera; Tania F Kanonnikoff; Magnus Nilsson; Matthias Guckenberger; Stefan Monig; Dorethea Wagner; Lucjan Wyrwicz; Maaike Berbee; Ines Gockel; Florian Lordick; Ewen A Griffiths; Marcel Verheij; Peter S N van Rossum; Hanneke W M van Laarhoven
Journal:  Eur J Cancer       Date:  2022-02-05       Impact factor: 9.162

4.  An International Multicenter Study Exploring Whether Surveillance After Esophageal Cancer Surgery Impacts Oncological and Quality of Life Outcomes (ENSURE).

Authors:  Jessie A Elliott; Sheraz R Markar; Fredrik Klevebro; Asif Johar; Lucas Goense; Pernilla Lagergren; Giovanni Zaninotto; Richard van Hillegersberg; Mark I van Berge Henegouwen; Magnus Nilsson; George B Hanna; John V Reynolds
Journal:  Ann Surg       Date:  2022-01-27       Impact factor: 13.787

5.  Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.

Authors:  Joel Shapiro; J Jan B van Lanschot; Maarten C C M Hulshof; Pieter van Hagen; Mark I van Berge Henegouwen; Bas P L Wijnhoven; Hanneke W M van Laarhoven; Grard A P Nieuwenhuijzen; Geke A P Hospers; Johannes J Bonenkamp; Miguel A Cuesta; Reinoud J B Blaisse; Olivier R C Busch; Fiebo J W Ten Kate; Geert-Jan M Creemers; Cornelis J A Punt; John Th M Plukker; Henk M W Verheul; Ernst J Spillenaar Bilgen; Herman van Dekken; Maurice J C van der Sangen; Tom Rozema; Katharina Biermann; Jannet C Beukema; Anna H M Piet; Caroline M van Rij; Janny G Reinders; Hugo W Tilanus; Ewout W Steyerberg; Ate van der Gaast
Journal:  Lancet Oncol       Date:  2015-08-05       Impact factor: 41.316

6.  Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.

Authors:  Eddie K Abdalla; Jean-Nicolas Vauthey; Lee M Ellis; Vickie Ellis; Raphael Pollock; Kristine R Broglio; Kenneth Hess; Steven A Curley
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.